Advertisement
Long-term relationship building and engagement key to gaining community trust
Enroll patients now in KEYNOTE-630 trial
Another option for immunotherapy
It nearly doubles median disease-free survival
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Join our staff as we present or participate in these presentations
The short answer from Chairman Conor Delaney, MD, PhD
New meta-analysis helps resolve the controversy
ASCO panels provide evidence-based recommendations
New treatment option for pre-treated patients
Immune and genetic biomarkers predict response rates
Advertisement
Advertisement